The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors

Tiziana Bisogno, Mauro Maccarrone, Luciano De Petrocellis, Abbas Jarrahian, Alessandro Finazzi-Agrò, Cecilia Hillard, Vincenzo Di Marzo

Research output: Contribution to journalArticle

Abstract

It is not yet clear if the endocannabinoid 2-arachidonoyl-glycerol (2-AG) is transported into cells through the same membrane transporter mediating the uptake of the other endogenous cannabinoid, anandamide (N-arachidonoyl-ethanolamine, AEA), and whether this process (a) is regulated by cells and (b) limits 2-AG pharmacological actions. We have studied simultaneously the facilitated transport of [14C]AEA and [3H]2-AG into rat C6 glioma cells and found uptake mechanisms with different efficacies but similar affinities for the two compounds (Km 11.0 ± 2.0 and 15.3 ± 3.1 μ, Bmax 1.70 ± 0.30 and 0.24 ± 0.04 nmol·min-1·mg protein-1, respectively). Despite these similar Km values, 2-AG inhibits [14C]AEA uptake by cells at concentrations (Ki ± 30.1 ± 3.9 μ) significantly higher than those required to either 2-AG or AEA to inhibit [3H]2-AG uptake (Ki ± 18.9 ± 1.8 and 20.5 ± 3.2 μ, respectively). Furthermore: (a) if C6 cells are incubated simultaneously with identical concentrations of [14C]AEA and [3H]2-AG, only the uptake of the latter compound is significantly decreased as compared to that observed with [3H]2-AG alone; (b) the uptake of [14C]AEA and [3H]2-AG by cells is inhibited with the same potency by AM404 (Ki ± 7.5 ± 0.7 and 10.2 ± 1.7 μ, respectively) and linvanil (Ki ± 9.5 ± 0.7 and 6.4 ± 1.2 μ, respectively), two inhibitors of the AEA membrane transporter; (c) nitric oxide (NO) donors enhance the uptake of both [14C]AEA and [3H]2-AG, thus suggesting that 2-AG action can be regulated through NO release; (d) AEA and 2-AG induce a weak release of NO that can be blocked by a CB1 cannabinoid receptor antagonist, and significantly enhanced in the presence of AM404 and linvanil, thus suggesting that transport into C6 cells limits the action of both endocannabinoids.

Original languageEnglish
Pages (from-to)1982-1989
Number of pages8
JournalEuropean Journal of Biochemistry
Volume268
Issue number7
DOIs
Publication statusPublished - 2001

Fingerprint

Cannabinoid Receptor Agonists
Ethanolamine
Endocannabinoids
Membrane Transport Proteins
2-arachidonylglycerol
Nitric Oxide
Cannabinoid Receptor Antagonists
Nitric Oxide Donors
Cannabinoids
Glioma
Rats

Keywords

  • Anandamide
  • Cannabinoid
  • Endocannabinoid
  • Nitric oxide
  • Transporter

ASJC Scopus subject areas

  • Biochemistry

Cite this

Bisogno, T., Maccarrone, M., De Petrocellis, L., Jarrahian, A., Finazzi-Agrò, A., Hillard, C., & Marzo, V. D. (2001). The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. European Journal of Biochemistry, 268(7), 1982-1989. https://doi.org/10.1046/j.1432-1327.2001.02072.x

The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. / Bisogno, Tiziana; Maccarrone, Mauro; De Petrocellis, Luciano; Jarrahian, Abbas; Finazzi-Agrò, Alessandro; Hillard, Cecilia; Marzo, Vincenzo Di.

In: European Journal of Biochemistry, Vol. 268, No. 7, 2001, p. 1982-1989.

Research output: Contribution to journalArticle

Bisogno, T, Maccarrone, M, De Petrocellis, L, Jarrahian, A, Finazzi-Agrò, A, Hillard, C & Marzo, VD 2001, 'The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors', European Journal of Biochemistry, vol. 268, no. 7, pp. 1982-1989. https://doi.org/10.1046/j.1432-1327.2001.02072.x
Bisogno, Tiziana ; Maccarrone, Mauro ; De Petrocellis, Luciano ; Jarrahian, Abbas ; Finazzi-Agrò, Alessandro ; Hillard, Cecilia ; Marzo, Vincenzo Di. / The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. In: European Journal of Biochemistry. 2001 ; Vol. 268, No. 7. pp. 1982-1989.
@article{204d4f31049e4033b82aa35bf8af3b15,
title = "The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors",
abstract = "It is not yet clear if the endocannabinoid 2-arachidonoyl-glycerol (2-AG) is transported into cells through the same membrane transporter mediating the uptake of the other endogenous cannabinoid, anandamide (N-arachidonoyl-ethanolamine, AEA), and whether this process (a) is regulated by cells and (b) limits 2-AG pharmacological actions. We have studied simultaneously the facilitated transport of [14C]AEA and [3H]2-AG into rat C6 glioma cells and found uptake mechanisms with different efficacies but similar affinities for the two compounds (Km 11.0 ± 2.0 and 15.3 ± 3.1 μ, Bmax 1.70 ± 0.30 and 0.24 ± 0.04 nmol·min-1·mg protein-1, respectively). Despite these similar Km values, 2-AG inhibits [14C]AEA uptake by cells at concentrations (Ki ± 30.1 ± 3.9 μ) significantly higher than those required to either 2-AG or AEA to inhibit [3H]2-AG uptake (Ki ± 18.9 ± 1.8 and 20.5 ± 3.2 μ, respectively). Furthermore: (a) if C6 cells are incubated simultaneously with identical concentrations of [14C]AEA and [3H]2-AG, only the uptake of the latter compound is significantly decreased as compared to that observed with [3H]2-AG alone; (b) the uptake of [14C]AEA and [3H]2-AG by cells is inhibited with the same potency by AM404 (Ki ± 7.5 ± 0.7 and 10.2 ± 1.7 μ, respectively) and linvanil (Ki ± 9.5 ± 0.7 and 6.4 ± 1.2 μ, respectively), two inhibitors of the AEA membrane transporter; (c) nitric oxide (NO) donors enhance the uptake of both [14C]AEA and [3H]2-AG, thus suggesting that 2-AG action can be regulated through NO release; (d) AEA and 2-AG induce a weak release of NO that can be blocked by a CB1 cannabinoid receptor antagonist, and significantly enhanced in the presence of AM404 and linvanil, thus suggesting that transport into C6 cells limits the action of both endocannabinoids.",
keywords = "Anandamide, Cannabinoid, Endocannabinoid, Nitric oxide, Transporter",
author = "Tiziana Bisogno and Mauro Maccarrone and {De Petrocellis}, Luciano and Abbas Jarrahian and Alessandro Finazzi-Agr{\`o} and Cecilia Hillard and Marzo, {Vincenzo Di}",
year = "2001",
doi = "10.1046/j.1432-1327.2001.02072.x",
language = "English",
volume = "268",
pages = "1982--1989",
journal = "European Journal of Biochemistry",
issn = "0014-2956",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors

AU - Bisogno, Tiziana

AU - Maccarrone, Mauro

AU - De Petrocellis, Luciano

AU - Jarrahian, Abbas

AU - Finazzi-Agrò, Alessandro

AU - Hillard, Cecilia

AU - Marzo, Vincenzo Di

PY - 2001

Y1 - 2001

N2 - It is not yet clear if the endocannabinoid 2-arachidonoyl-glycerol (2-AG) is transported into cells through the same membrane transporter mediating the uptake of the other endogenous cannabinoid, anandamide (N-arachidonoyl-ethanolamine, AEA), and whether this process (a) is regulated by cells and (b) limits 2-AG pharmacological actions. We have studied simultaneously the facilitated transport of [14C]AEA and [3H]2-AG into rat C6 glioma cells and found uptake mechanisms with different efficacies but similar affinities for the two compounds (Km 11.0 ± 2.0 and 15.3 ± 3.1 μ, Bmax 1.70 ± 0.30 and 0.24 ± 0.04 nmol·min-1·mg protein-1, respectively). Despite these similar Km values, 2-AG inhibits [14C]AEA uptake by cells at concentrations (Ki ± 30.1 ± 3.9 μ) significantly higher than those required to either 2-AG or AEA to inhibit [3H]2-AG uptake (Ki ± 18.9 ± 1.8 and 20.5 ± 3.2 μ, respectively). Furthermore: (a) if C6 cells are incubated simultaneously with identical concentrations of [14C]AEA and [3H]2-AG, only the uptake of the latter compound is significantly decreased as compared to that observed with [3H]2-AG alone; (b) the uptake of [14C]AEA and [3H]2-AG by cells is inhibited with the same potency by AM404 (Ki ± 7.5 ± 0.7 and 10.2 ± 1.7 μ, respectively) and linvanil (Ki ± 9.5 ± 0.7 and 6.4 ± 1.2 μ, respectively), two inhibitors of the AEA membrane transporter; (c) nitric oxide (NO) donors enhance the uptake of both [14C]AEA and [3H]2-AG, thus suggesting that 2-AG action can be regulated through NO release; (d) AEA and 2-AG induce a weak release of NO that can be blocked by a CB1 cannabinoid receptor antagonist, and significantly enhanced in the presence of AM404 and linvanil, thus suggesting that transport into C6 cells limits the action of both endocannabinoids.

AB - It is not yet clear if the endocannabinoid 2-arachidonoyl-glycerol (2-AG) is transported into cells through the same membrane transporter mediating the uptake of the other endogenous cannabinoid, anandamide (N-arachidonoyl-ethanolamine, AEA), and whether this process (a) is regulated by cells and (b) limits 2-AG pharmacological actions. We have studied simultaneously the facilitated transport of [14C]AEA and [3H]2-AG into rat C6 glioma cells and found uptake mechanisms with different efficacies but similar affinities for the two compounds (Km 11.0 ± 2.0 and 15.3 ± 3.1 μ, Bmax 1.70 ± 0.30 and 0.24 ± 0.04 nmol·min-1·mg protein-1, respectively). Despite these similar Km values, 2-AG inhibits [14C]AEA uptake by cells at concentrations (Ki ± 30.1 ± 3.9 μ) significantly higher than those required to either 2-AG or AEA to inhibit [3H]2-AG uptake (Ki ± 18.9 ± 1.8 and 20.5 ± 3.2 μ, respectively). Furthermore: (a) if C6 cells are incubated simultaneously with identical concentrations of [14C]AEA and [3H]2-AG, only the uptake of the latter compound is significantly decreased as compared to that observed with [3H]2-AG alone; (b) the uptake of [14C]AEA and [3H]2-AG by cells is inhibited with the same potency by AM404 (Ki ± 7.5 ± 0.7 and 10.2 ± 1.7 μ, respectively) and linvanil (Ki ± 9.5 ± 0.7 and 6.4 ± 1.2 μ, respectively), two inhibitors of the AEA membrane transporter; (c) nitric oxide (NO) donors enhance the uptake of both [14C]AEA and [3H]2-AG, thus suggesting that 2-AG action can be regulated through NO release; (d) AEA and 2-AG induce a weak release of NO that can be blocked by a CB1 cannabinoid receptor antagonist, and significantly enhanced in the presence of AM404 and linvanil, thus suggesting that transport into C6 cells limits the action of both endocannabinoids.

KW - Anandamide

KW - Cannabinoid

KW - Endocannabinoid

KW - Nitric oxide

KW - Transporter

UR - http://www.scopus.com/inward/record.url?scp=0034850220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034850220&partnerID=8YFLogxK

U2 - 10.1046/j.1432-1327.2001.02072.x

DO - 10.1046/j.1432-1327.2001.02072.x

M3 - Article

C2 - 11277920

AN - SCOPUS:0034850220

VL - 268

SP - 1982

EP - 1989

JO - European Journal of Biochemistry

JF - European Journal of Biochemistry

SN - 0014-2956

IS - 7

ER -